Latest News
From Digital Transformation to Operational Intelligence in Healthcare
Healthcare has never really had a technology problem. The greater challenge has been turning technology into better ways of working. Over the past decade, healthcare organizations have invested heavily in electronic health records, digital services, automation,...
Latest News
NAMs and Animal Testing: Separating Progress From Hype
If you followed the headlines over the past two years, you could be forgiven for thinking animal testing in drug development is already on its way out. In December 2022, the FDA Modernization Act 2.0 removed the blanket legal requirement for animal studies to support...
Clinical Trials Roundup | 17 July 2026
Celcuity's gedatolisib receives FDA approval as the first pan-PI3K and mTOR inhibitor for advanced breast cancer, Biogen's diranersen delivers detailed Phase 2 CELIA data showing tau reduction and cognitive benefit in early Alzheimer's disease, Novo Nordisk's...
Biopharma H1 2026 Review: Deals, Drugs, and Pipeline Shifts
The first half of 2026 delivered one of the most consequential periods in recent biopharma history, reshaping competitive landscapes through record dealmaking, landmark regulatory approvals, and pivotal clinical breakthroughs. This biopharma H1 2026 review examines...
AI Can Do More Than Summarize Medicine—It Can Help Generate Evidence
Our healthcare system has built a rigorous process for generating the evidence that clinicians, researchers and pharmaceutical companies rely on. Designing studies, conducting clinical trials, analyzing data, completing regulatory review and publishing results are all...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Rethinking the Male Factor in IVF: Why New Sperm Technologies Matter
For much of the history of in-vitro fertilisation (IVF), technological advances have focused overwhelmingly on the egg and the embryo. Advances in ovarian stimulation protocols, time-lapse embryo imaging, genetic testing and cryopreservation have dramatically improved...
Why Pharma’s Commercial Model is Failing Precision Medicine
Pharma generates more insight than ever. Translating that insight into timely action is where the system falters, and the gap runs deeper than most commercial leaders are willing to admit. Over the past decade, omnichannel systems have matured considerably. CRM...
Teaching Children Conscious Self-Regulation for Life Outcomes
A Neurodevelopmental Framework for Strategic Life Construction In an era defined by rapid technological change, algorithmic persuasion, and rising rates of youth anxiety, the question is no longer whether children need education, but what kind of education is most...
Why Amazing Medical Technologies Fail (And How to Ensure Yours Doesn’t)
Have you considered what it means to have an FDA-approved, life-changing, medical product? It’s nothing short of amazing! However, let me add on to that question, have you considered what it means to have an FDA-approved, life changing, medical product WITHOUT a...
Making Pre-Commercial Marketing Technology Work Under Launch Pressure
In pre-commercial life sciences environments, marketing technology (MarTech) platforms are often implemented well before launch. Teams select, configure, and integrate systems quickly, expecting campaigns to perform flawlessly. But small gaps in governance, ownership,...
Thermo Fisher Scientific Opens New Distribution Center in Ireland
70,000 sq. ft. facility expands the company's biopharma, chemical and cold chain storage capacities DUBLIN, Ireland, (March 6, 2026) - Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution...
The Microbiome, as a Performance Regulator: Gut Integrity Under Physiological Load
In high-performance populations — elite athletes, tactical operators, founders, executives under sustained cognitive load — resilience is typically framed in terms of cardiovascular output, muscular strength, mitochondrial density or hormonal optimisation. Yet one of...
From Living Room to Lab: New Dementia Study to Close Participation Gap
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This...
Why a New Era of Medical Innovation is Taking Shape
Over the next decade, modern medicine is poised to undergo a redefinition that has not been seen in generations. The surge in innovation, transformational scientific discoveries and rapidly maturing technologies is redefining patient outcomes. The biotech industry is...
Activating Autophagy, Your Body’s Natural Metabolic Superpower
Did you know that your body has its own biological process for clearing out old or damaged cells, and recycling dysfunctional components to prioritize healthier, more productive ones? For billions of years, autophagy has acted as a kind of evolutionary survival...
Beyond the Basics: How Behavioral Intelligence and ML Reduce Trial Dropout
Medication non-adherence and dropout have long been labeled “known problems” in the clinical trial space. Yet despite years of tinkering with the formula, these challenges have only become “well-known problems.” Operational efficiencies and innovation, digital...
Why Health Platforms Built for Millennials Will Fail Gen Alpha
The first smartphone-native generation expects fundamentally different things from digital health and retrofitting won't work Gen Alpha (born roughly between 2010 and 2024) is the first generation to grow up entirely in a world where smartphones, AI assistants, and...
Rethinking the Male Factor in IVF: Why New Sperm Technologies Matter
For much of the history of in-vitro fertilisation (IVF), technological advances have focused overwhelmingly on the egg and the embryo. Advances in ovarian stimulation protocols, time-lapse embryo imaging, genetic testing and cryopreservation have dramatically improved...
Why Pharma’s Commercial Model is Failing Precision Medicine
Pharma generates more insight than ever. Translating that insight into timely action is where the system falters, and the gap runs deeper than most commercial leaders are willing to admit. Over the past decade, omnichannel systems have matured considerably. CRM...
Teaching Children Conscious Self-Regulation for Life Outcomes
A Neurodevelopmental Framework for Strategic Life Construction In an era defined by rapid technological change, algorithmic persuasion, and rising rates of youth anxiety, the question is no longer whether children need education, but what kind of education is most...
Why Amazing Medical Technologies Fail (And How to Ensure Yours Doesn’t)
Have you considered what it means to have an FDA-approved, life-changing, medical product? It’s nothing short of amazing! However, let me add on to that question, have you considered what it means to have an FDA-approved, life changing, medical product WITHOUT a...
Making Pre-Commercial Marketing Technology Work Under Launch Pressure
In pre-commercial life sciences environments, marketing technology (MarTech) platforms are often implemented well before launch. Teams select, configure, and integrate systems quickly, expecting campaigns to perform flawlessly. But small gaps in governance, ownership,...
Thermo Fisher Scientific Opens New Distribution Center in Ireland
70,000 sq. ft. facility expands the company's biopharma, chemical and cold chain storage capacities DUBLIN, Ireland, (March 6, 2026) - Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution...
The Microbiome, as a Performance Regulator: Gut Integrity Under Physiological Load
In high-performance populations — elite athletes, tactical operators, founders, executives under sustained cognitive load — resilience is typically framed in terms of cardiovascular output, muscular strength, mitochondrial density or hormonal optimisation. Yet one of...
From Living Room to Lab: New Dementia Study to Close Participation Gap
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This...
Why a New Era of Medical Innovation is Taking Shape
Over the next decade, modern medicine is poised to undergo a redefinition that has not been seen in generations. The surge in innovation, transformational scientific discoveries and rapidly maturing technologies is redefining patient outcomes. The biotech industry is...
Activating Autophagy, Your Body’s Natural Metabolic Superpower
Did you know that your body has its own biological process for clearing out old or damaged cells, and recycling dysfunctional components to prioritize healthier, more productive ones? For billions of years, autophagy has acted as a kind of evolutionary survival...
Beyond the Basics: How Behavioral Intelligence and ML Reduce Trial Dropout
Medication non-adherence and dropout have long been labeled “known problems” in the clinical trial space. Yet despite years of tinkering with the formula, these challenges have only become “well-known problems.” Operational efficiencies and innovation, digital...
Why Health Platforms Built for Millennials Will Fail Gen Alpha
The first smartphone-native generation expects fundamentally different things from digital health and retrofitting won't work Gen Alpha (born roughly between 2010 and 2024) is the first generation to grow up entirely in a world where smartphones, AI assistants, and...
Featured Articles
Further News
Summary: England Rare Diseases Action Plan 2026
The England Rare Diseases Action Plan 2026 outlines how the Department of Health and Social Care and partner organisations are delivering commitments under the UK Rare Diseases Framework to improve outcomes for people living with rare conditions in England. The report...
A Decentralized Advantage: Outpatient Theranostics is the Clinical Standard
While oncology has historically relied on a "Hospital-as-Hub" model, the specific logistical demands of radiopharmaceutical therapy (RPT) are revealing its limitations. The decentralized outpatient model is emerging as a significant industry trend, demonstrating that...
Why Patent Portfolios are Crucial for Life Science Innovators
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their innovations by implementing a strategic intellectual...
The Convergence Era: How Data and AI are Reshaping Life Sciences
For decades, innovation in life sciences followed a familiar path: lab discovery, clinical testing, regulatory approval, market release. It was linear. Predictable. Slow. What’s happening now feels different. The most significant shift isn’t a single breakthrough...
Atomic Warriors: How Structural Biology is Decoding the Next Pandemic
As the echoes of the COVID-19 crisis fade, humanity remains on high alert for the inevitable next pathogen. What if we could dissect viruses down to their atomic core, revealing chinks in their armor that lead to revolutionary treatments? Drawing from my 12+ years as...
Life Science and Biopharma in 2026: Insights from L.E.K. Consulting
The biopharma industry is at an inflection point as it enters 2026. Discoveries from the past year will be applied and scaled, particularly across AI-enabled drug development, advanced modalities and cardiometabolic disease treatment. These advancements will occur...
ESGO 2026: Elenagen Phase II Data in Platinum-Resistant OC
At the 2026 Congress of the European Society of Gynaecological Oncology (ESGO) in Copenhagen, Dr Gabriel Levin of the McGill University Health Centre will present Phase II data evaluating the investigational DNA therapy Elenagen in combination with gemcitabine for...
Global Funding Shifts Redraw Life Sciences Innovation Map
The life sciences sector is experiencing a fundamental reshaping of its innovation geography as funding pressures, policy shifts, and geopolitical tensions redraw the competitive landscape across continents. While research funding constraints in the United States...
MSD Reorganises to Shield Growth from Impending “Keytruda Cliff”
In its most significant structural overhaul since the 2021 Organon spin-off, MSD (known as Merck & Co. in the U.S. and Canada) has announced the division of its Human Health business into two standalone units: an Oncology Business Unit and a Specialty, Pharma...
Five Big Shifts Redefining the Future of Cell and Gene Therapy
Marking its success San Diego debut earlier this month, Phacilitate’s Advanced Therapies Week (ATW), brought together leaders, innovators, and industry stakeholders from around the world for a dynamic showcase of progress in cell and gene therapies (CGT). From...
Paving the Way in Telomere Biology: The Research of Dr. Kelly Nguyen
Kelly Nguyen is a molecular biologist and Group Leader in the Structural Studies Division at the MRC Laboratory of Molecular Biology (LMB), where her research aims to uncover how telomeres are structured, maintained and regulated by the enzyme telomerase. Telomeres...
Medical Bankruptcy: The Hidden Cost of U.S. Health Care
My wife underwent major surgery in December 2025. She remained 10 days in a Charlotte, NC, hospital and was then for several weeks supported at home by visiting nurses, a physical therapist and a dietician. We just saw the bill: The hospital and participating doctors...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.